Literature DB >> 6967351

Theoretical limitations in the immunodiagnostic imaging of cancer with computed tomography and nuclear scanning.

S D Rockoff, D J Goodenough, K R McIntire.   

Abstract

In order to help assess the feasibility of using immunologically tagged agents to render tumors detectable with current computed tomographic and nuclear scanners, mathematical formulations were developed to determine the theoretical limits of tumor detection relative to size and depth of the lesions. The results of our analysis suggest that visualization with computed tomography of a tiny tumor (1 sq mm, cross-sectional area) would require binding in the order of 2 x 10(5) iodine atoms/antigenic site, while imaging of a very large (900-sq mm) tumor would require approximately 10(4) atoms/site. Very low energy scanners might reduce these discouraging estimates by an order of 10(2). The immunological imaging of tumors with nuclear scanning appears quite feasible from our formulations, as has been demonstrated by others clinically. Small (1-sq cm) and deep (greater than or equal to 5-cm) tumors appear detectable with uptake ratios of the order of 5 or higher, which seem to be attainable currently. Smaller and deeper tumors require much higher uptake ratios to be detected.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6967351

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

Review 1.  Approaches to radiolabeling of antibodies for diagnosis and therapy of cancer.

Authors:  A R Fritzberg; R W Berninger; S W Hadley; D W Wester
Journal:  Pharm Res       Date:  1988-06       Impact factor: 4.200

2.  Radioimmunodetection of cancer: problems and potential.

Authors:  E M Rankin; J G McVie
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-12

3.  Radioimmunolocalization of human pancreatic carcinoma xenograft by 99mTc-labeled YPC3 monoclonal antibody.

Authors:  Q Chen; S Yuan
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

4.  Feasibility study of radioimmunoguided surgery of colorectal carcinomas using indium-111 CEA-specific monoclonal antibody.

Authors:  C Curtet; J P Vuillez; G Daniel; G Aillet; A Chetanneau; J Visset; M Kremer; P Thédrez; J F Chatal
Journal:  Eur J Nucl Med       Date:  1990

Review 5.  Antitumor monoclonal antibodies for radioimmunodetection of tumors and drug targeting.

Authors:  R W Baldwin; M V Pimm
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

6.  Improved tumour localisation using indium-111 labelled antibodies.

Authors:  D S Fairweather; A R Bradwell; P W Dykes; A T Vaughan; S F Watson-James; S Chandler
Journal:  Br Med J (Clin Res Ed)       Date:  1983-07-16

7.  Limits of Tumor Detectability in Nuclear Medicine and PET.

Authors:  Yusuf Emre Erdi
Journal:  Mol Imaging Radionucl Ther       Date:  2012-04-01

8.  The detection of axillary lymph node metastases from breast cancer by radiolabelled monoclonal antibodies: a prospective study.

Authors:  J J Tjandra; N P Sacks; C H Thompson; M J Leyden; S A Stacker; M Lichtenstein; I S Russell; J P Collins; J T Andrews; G A Pietersz
Journal:  Br J Cancer       Date:  1989-02       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.